Structural elucidation of degradation products of a benzopyridooxathiazepine under stress conditions using electrospray orbitrap mass spectrometry – Study of degradation kinetic (original) (raw)

Identification of degradation products of saquinavir mesylate by ultra-high-performance liquid chromatography/electrospray ionization quadrupole time-of-flight tandem mass spectrometry and its application to quality control

Dr Debasish Swain

Rapid Communications in Mass Spectrometry, 2017

View PDFchevron_right

The use of liquid chromatography±mass spectrometry for the identi®cation of drug degradation products in pharmaceutical formulations

Marco Garzotti

View PDFchevron_right

Identification of stress degradation products of iloperidone using liquid chromatography coupled with an Orbitrap mass spectrometer

Tofan Rout

Rapid communications in mass spectrometry : RCM, 2017

View PDFchevron_right

Slow, spontaneous degradation of lansoprazole, omeprazole and pantoprazole tablets: isolation and structural characterization of the toxic antioxidants 3H-benzimidazole-2-thiones

Marwan Touma

View PDFchevron_right

Use of LC–MS/TOF, LC–MSn, NMR and LC–NMR in characterization of stress degradation products: Application to cilazapril

Archana Sahu

Journal of Pharmaceutical and Biomedical Analysis, 2015

View PDFchevron_right

Kinetic study on the degradation of prazepam in acidic aqueous solutions by high-performance liquid chromatography and fourth-order derivative ultraviolet spectrophotometry

Irene Panderi

Journal of Pharmaceutical and Biomedical Analysis, 1998

View PDFchevron_right

Degradation studies of quetiapine fumarate by liquid chromatography–diode array detection and tandem mass spectrometry methods

Marta De Diego

Biomedical Chromatography, 2019

View PDFchevron_right

Identification of Degradation Products in Cyclophosphamide API by LC-QTOF Mass Spectrometry Identification of Degradation Products in Cyclophosphamide API by LC-QTOF Mass Spectrometry

shiva gudlawar

View PDFchevron_right

Identification and Characterization of Degradation Products of Lacosamide by Liquid-Chromatography/Time-Of-Flight Mass Spectrometric and Multi-Stage Mass Spectrometric Analysis

Ritesh Bhole

Journal of Liquid Chromatography & Related Technologies, 2014

View PDFchevron_right

Characterization of imazamox degradation by-products by using liquid chromatography mass spectrometry and high-resolution Fourier transform ion cyclotron resonance mass spectrometry

András Gáspár

Analytical and Bioanalytical Chemistry, 2007

View PDFchevron_right

Structure elucidation of degradation products of the antibiotic amoxicillin with ion trap MSn and accurate mass determination by ESI TOF

Dr S. Venkat Rao

Journal of the American Society for Mass Spectrometry, 2005

View PDFchevron_right

Study of Forced Degradation Behaviour of Brinzolamide Using LC–ESI–Q-TOF and In Silico Toxicity Prediction

Dr Debasish Swain

Chromatographia, 2016

View PDFchevron_right

Strategy for identification and characterization of small quantities of drug degradation products using LC and LC-MS: Application to valsartan, a model drug

Saranjit Singh

Drug Testing and Analysis, 2010

View PDFchevron_right

Ultraviolet-photodiode array and high-performance liquid chromatographic/mass spectrometric studies on forced degradation behavior of glibenclamide and development of a validated stability-indicating method

Saranjit Singh

Journal of AOAC International

View PDFchevron_right

Identification, Isolation, and Structural Characterization of Novel Forced Degradation Products of Darunavir Using Advanced Analytical Techniques Like UPLC–MS, Prep-HPLC, HRMS, NMR, and FT-IR Spectroscopy

Ramusamineni Sri

Chromatographia

View PDFchevron_right

LC-MS/MS structural characterization of stress degradation products including the development of a stability indicating assay of Darunavir: An anti-HIV drug

Dr. Bondigalla Ramachandra

Journal of Pharmaceutical and Biomedical Analysis, 2014

View PDFchevron_right

LC, LC-MS/MS studies for the identification and characterization of degradation products of hydrochlorothiazide and establishment of mechanistic approach towards degradation

Sandeep Kale

Journal of the Brazilian Chemical Society, 2012

View PDFchevron_right

Forced degradation study of efonidipine HCl ethanolate, characterization of degradation products by LC-Q-TOF-MS and NMR

Charu Pandya

Journal of Applied Pharmaceutical Science, 2020

View PDFchevron_right

Forced Degradation Study of Quinapril by UPLC-DAD and UPLC/ MS/MS: Identification of By-products and Development of Degradation Kinetics

Maha Dendeni

Current Pharmaceutical Analysis, 2013

View PDFchevron_right

Forced degradation studies of lansoprazole using LC-ESI HRMS and 1 H-NMR experiments: in vitro toxicity evaluation of major degradation products

Nagesh Narayana

Journal of Mass Spectrometry, 2017

View PDFchevron_right

LC, MS n and LC-MS/MS studies for the characterization of degradation products of amlodipine

Anand Avinash Mahajan

Journal of pharmaceutical analysis, 2015

View PDFchevron_right

IDENTIFICATION, SEPARATION, AND CHARACTERIZATION OF DEGRADATION PRODUCTS OF TRIAMCINOLONE HEXACETONIDE USING LC AND LC-MS/MS

International Journal of Applied Pharmaceutics (IJAP), BHAVNA SUNIL MAHAJAN

International Journal of Applied Pharmaceutics, 2024

View PDFchevron_right

Forced degradation study of different brands of levocetirizine dihydrochloride by UV-spectroscopy

Zamir Khan

International Journal of Pharmaceutical Chemistry and Analysis, 2020

View PDFchevron_right

An Introduction to Forced degradation studies for drug substances and drug products

MUSKAN singh

Journal of emerging technologies and innovative research, 2021

View PDFchevron_right

Review: Development of forced degradation studies of drugs

Scholar Science Journals

View PDFchevron_right

Utilisation of electrospray time-of-flight mass spectrometry for solving complex fragmentation patterns: application to benzoxazinone derivatives

Thomas Knepper

Journal of Mass Spectrometry, 2003

View PDFchevron_right

HPLC–DAD method for investigating pantoprazole for its stress-dependent degradation by photolysis and oxidation

Neelaveni Thangavel

Acta Chromatographica, 2020

View PDFchevron_right

MS/MS and HPLC characterization of forced degradation products of clopidogrel and pantoprazole sodium

Jinesh Nagavi

International Journal of Drug Development and Research, 2018

View PDFchevron_right

Column liquid chromatography-ultraviolet and column liquid chromatography/mass spectrometry evaluation of stress degradation behavior of escitalopram oxalate

Prof Dr Sunil Dhaneshwar

Journal of AOAC International

View PDFchevron_right

Forced Degradation Study for Simultaneous Quantification of Aspirin and Omeprazole in Pharmaceutical Dosage form by RP-HPLC

chandni chandarana

Journal of Pharmaceutical Research International

View PDFchevron_right

Electrochemical oxidation coupled with liquid chromatography and mass spectrometry to study the oxidative stability of active pharmaceutical ingredients in solution: A comparison of off-line and on-line approaches

Roman Szucs

Journal of pharmaceutical and biomedical analysis, 2016

View PDFchevron_right

Characterization of degradation products of macitentan under various stress conditions using liquid chromatography/mass spectrometry

Jean-claude Tabet

Rapid communications in mass spectrometry : RCM, 2018

View PDFchevron_right

Isolation, identification, and synthesis of two oxidative degradation products of olanzapine (LY170053) in solid oral formulations

craig kemp

Journal of Pharmaceutical Sciences, 2008

View PDFchevron_right